ActosBladderCancer

In the first three quarters of 2010 there were 2.3 million prescriptions filled for the type 2 diabetes drug Actos.  Because of the sales volume of this drug it has been called a blockbuster drug.  Yet only recently has evidence surfaced noting that patients taking Actos for more than one year are at a 40% increased risk of bladder cancer. The drug has been pulled from the market in both Germany and France. Yet, here in American the FDA has simply stated that they will continue to monitor the situation.  WE SAY - NOT ENOUGH FDA!  WE CALL FOR A  RECALL OF ACTOS.